General Information of Drug (ID: DM5PK9S)

Drug Name
LX-1033
Indication
Disease Entry ICD 11 Status REF
Irritable bowel syndrome DD91.0 Phase 2 [1]
Cross-matching ID
TTD ID
D0FA5Z

References

1 ClinicalTrials.gov (NCT01494233) A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome. U.S. National Institutes of Health.